Savara (NASDAQ: SVRA) updates corporate presentation for investors

Rhea-AI Filing Summary

Savara Inc. has furnished an updated corporate presentation for investors. The presentation is available on the company’s Investor Relations website and has also been provided as Exhibit 99.1 to a current report. Savara states it has no duty to update or revise the presentation, although it may choose to do so through its website, future SEC reports, press releases, or other public disclosures. The information in this investor presentation is expressly treated as furnished rather than filed under securities laws and is not automatically incorporated into other SEC filings unless specifically referenced.

Savara Inc false 0001160308 0001160308 2026-01-09 2026-01-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

January 9, 2026

SAVARA INC.

(Exact name of registrant as specified in its charter)

Delaware		001-32157		84-1318182
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1717 Langhorne Newtown Road, Suite 300

Langhorne, PA 19047

(Address of principal executive offices, including zip code)

(512) 614-1848

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		SVRA		The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

Savara has updated its corporate presentation, which is available on the Investor Relations page of Savara’s website at https://investors.savarapharma.com/overview/default.aspx. A copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Savara undertakes no duty or obligation to update or revise the information contained in this presentation, although it may do so from time to time. Any such updates may be made through the Investor Relations page of the Savara website, the filing of other reports or documents with the U.S. Securities and Exchange Commission (the “SEC”), press releases, or other public disclosure.

The information in Item 7.01 in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Savara Corporate Presentation
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 9, 2026						SAVARA INC. a Delaware corporation
				By:		/s/ Dave Lowrance
						Dave Lowrance Chief Financial & Administrative Officer

FAQ

What did Savara Inc. (SVRA) disclose in this 8-K filing?

Savara Inc. disclosed that it has updated its corporate presentation and made it available on the Investor Relations page of its website, while also furnishing it as Exhibit 99.1 to a current report.

Where can investors access Savara Inc. (SVRA)’s updated corporate presentation?

Investors can access Savara’s updated corporate presentation on the Investor Relations page of its website at https://investors.savarapharma.com/overview/default.aspx and in Exhibit 99.1 to the current report.

Does Savara Inc. have an obligation to update the corporate presentation?

Savara states it undertakes no duty or obligation to update or revise the information in the corporate presentation, although it may do so from time to time through its website, SEC reports, press releases, or other public disclosure.

Is Savara Inc.’s updated presentation considered filed under Section 18 of the Exchange Act?

The company specifies that the information in this investor presentation is furnished and shall not be deemed filed for purposes of Section 18 of the Exchange Act or otherwise subject to that section’s liabilities.

Will the Savara Inc. (SVRA) presentation be automatically incorporated into other SEC filings?

Savara indicates the presentation will not be incorporated by reference into Securities Act or Exchange Act filings except where expressly set forth by specific reference in such a filing.

What exhibit number contains Savara Inc.’s updated corporate presentation?

The updated corporate presentation is included as Exhibit 99.1 to the current report, with an additional Exhibit 104 covering the inline XBRL cover page data file.